A woman displays the products of Ramadan culinary arts in the “Ramadan Market” activities, which were implemented in the Arbaeen Lake Park in historical Jeddah. (SPA)
Read next
Digital Therapeutics Face Regulatory and Reimbursement Hurdles in European Markets
Prescription software applications encounter varying country-by-country approval pathways despite unified clinical safety guidelines.
Inflammation: What It Is and What the Word Is Doing in Marketing
A genuine biological process, and a word attached to a great many products that do not affect it.
GLP-1 Class Therapies Restructure Corporate Food Strategy
Widespread adoption of metabolic medications forces fast-moving consumer goods companies to adjust caloric profiles.
GLP-1 Class Drugs Reshape Pharmaceutical Pipelines and MedTech Valuations
The rapid adoption of metabolic therapies is altering long-term forecasts for cardiovascular, orthopedic, and medical device sectors.
Pharmaceutical Supply Chains Expand API Capacity for Metabolic Drugs
Active pharmaceutical ingredient manufacturers invest in continuous manufacturing to resolve global GLP-1 shortages.
Clinical Trial Automation Accelerates Targeted Therapeutics Timeline
Pharmaceutical developers leverage algorithmic patient-matching platforms to reduce phase-two oncology recruitment phases.